Jarl Emanuel Strange (@JarlStrange) profile picture

The real DocStrange. MD, PhD. Copenhagen Univserity Hospital, Rigshospitalet & Herlev-Gentofte Hospital. Interested in cardiology.

Joined February 2020
Photo by Jarl Emanuel Strange (@JarlStrange)
Important contemporary data on patients with MI. Non-CV morbidity is increasing over time which may challenge patient care. Perhaps this area warrants further attention in the future? Out in JACC by talented @DanielMolager
This Post is from an account that no longer exists. Learn more
1
8
400
Patient characteristics and #microbiology 🦠 of #endocarditis after #tavi. How does it compare to other groups of IE? Data remain sparse, yet the patient group will likely grow with the increased use of tavi worldwide. Check out our latest #OpenAccess 🔓study in @CIDJournal.
Patient characteristics, microbiology, and mortality of infective endocarditis after transcatheter aortic valve implantation ✅ Just Accepted 🔓 Open Access 🔗 bit.ly/3XYnXdE
2
2
15
1,341
Jarl Emanuel Strange retweeted
Risk of Worsening Heart Failure and All-Cause Mortality Following COVID-19 Vaccination in Patients With Heart Failure: A Nationwide Real-World Safety Study #AHAJournals @TorBiering @ca_heart_dk @mortschou @JarlStrange @DanielMolager ahajournals.org/doi/abs/10.1…
1
5
2
14
3,461
En fornøjelse at tale om et vigtigt emne, som kun kommer til at fylde mere i fremtiden. Dejligt med engagerede lyttere med en god efterfølgende faglig diskussion.
This Post is from an account that no longer exists. Learn more
8
387
What is the association between #frailty and time in hospital following #TAVR? Find out in @JAHA_AHA Frail patients have an⬆️risk of death & complications. For these patients, life-expectancy is limited and time in hospital is central for quality of life, yet data remain sparse
2
3
8
635
At 1 year after discharge from TAVR, 26.4% of highly frail patients were hospitalized for >2 weeks and 15.6% were dead. By contrast, only 10.8% of low frailty patients were hospitalized >2 weeks and 5.8% were dead.
1
212
Our data suggest that prevention strategies for frail patients to reduce hospitalization burden are warranted. Read the full study in @JAHA_AHA bitly.ws/D6f6 @CopCard @RigsHeart
3
5
514
Do patients who receive TAVI more often end up in nursing homes than matched controls? 🤔 Watch the video with @JarlStrange to get the answer, or read the article in JACC Cardiovascular Interventions here (or do both) sciencedirect.com/science/ar… @gunngis @JBjerringOlesen @EmilFosb
5
1
21
2,312
Jarl Emanuel Strange retweeted
In a Danish nationwide cohort, undergoing #TAVR was not assoc. w/ an increased risk of nursing home admission vs general population. Approx. 2 out of 3 patients aged >85 were still alive & not admitted to a nursing home 3 yrs after TAVR. https://nitter.cf/t.co/4BdvBhhIRv #JACCINT
4
2
15
5,242
What is the incidence of nursing home admission after #TAVR? Spoiler: Good news! Nursing home admission rates for patients undergoing #TAVR are comparable to the general population. New study published in @JACCJournals #JACCINT 👀jacc.org/doi/10.1016/j.jcin.… @RigsHeart @CopCard
1
4
18
1,194
In fact, among TAVR patients aged >85 years, approximately two out of three patients were still alive and not admitted to a nursing home three years after TAVR.
1
2
139
Factors associated with nursing home admission were ⬆️age, ⬆️frailty, living alone, and atrial fibrillation. These are important, encouraging news to be shared with patients undergoing TAVR.
2
126
Jarl Emanuel Strange retweeted
Check out our new paper in @ESC_Journals Europace on #thyroiddysfunction after initiation of #amiodarone led by rising star Sam Ayad Ali in a Danish nationwide cohort #CardioTwitter #Cardiology
2
16
53
Jarl Emanuel Strange retweeted
In Press, Open Access: Prognosis of acute coronary syndrome stratified by cancer type and status -A nationwide cohort study. sciencedirect.com/science/ar…
3
4
New study by PL Graversen in @Heart_BMJ. Contemporary data on AVR in Denmark. AVR ↗️ mainly due to TAVI - especially in the elderly. But also in patients < 70 years. Different from US data with almost 50% TAVI in patients < 65 years 👀 bitly.ws/xyHH @RigsHeart @CopCard
1
2
1
23
Also great editorial by @mmamas1973 @valeriaparadies summarizing some of the challenges ahead with the increasing use and expanding indications of TAVI. Check it out bitly.ws/xyJr
1
4
Important contribution to the growing field of cardio-oncology. How does cancer type & status impact the prognosis of ACS? What is the cause of death? How are they managed? All important questions addressed by @NinaNouhravesh Find out below! bitly.ws/wKcG
Hjerte-kar-sygdomme var den hyppigste dødsårsag hos patienter med aktive og ikke-aktive kræft 🦀 Nyt studie fra @NinaNouhravesh, @MortenLamberts fra @HGHHjerte og kollegaer i @AmericanHeartJ sciencedirect.com/science/ar…
2
5
11